Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tocotrienol Against the Progression of End Stage Liver Disease

NCT02581085 is registered in ClinicalTrials.gov with Chandan Sen as lead sponsor.

NCT NCT02581085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02581085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tocotrienol Against the Progression of End Stage Liver Disease
Lead sponsor
Chandan Sen
Phase
Phase 2
Overall status
Completed
Start date
November 1, 2019
Completion date
December 16, 2025
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage liver disease, nafld - nonalcoholic fatty liver disease, nash - nonalcoholic steatohepatitis